Patent 10517897 was granted and assigned to Rubius Therapeutics on December, 2019 by the United States Patent and Trademark Office.
The invention includes compositions and methods related to multimodal therapies, e.g., for treating a cancer. A multimodal therapy described herein provides and/or administers a plurality of agents that function in a coordinated manner to provide a therapeutic benefit to a subject in need thereof, e.g., a subject having a cancer.